Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmaceutics

Background:

• Liposomes are FDA-approved nanoparticle carriers for drug delivery due to their biocompatibility.
• Current research focuses on bioconjugation to improve liposome efficacy.
• Bioconjugation enhances drug loading, targeting, and overall therapeutic outcomes.

Purpose of the Study:

• To review recent advances in bioconjugation strategies for liposome-mediated drug delivery.
• To highlight improvements in drug loading and targeted delivery.
• To discuss the clinical relevance and future directions of bioconjugated liposomes.

Main Methods:

• Literature review of studies published in the last five years.
• Focus on bioconjugation techniques applied to liposomes.
• Analysis of improvements in drug loading and targeting efficiency.

Main Results:

• Bioconjugation significantly improves drug loading capacity in liposomes.
• Targeted delivery of liposomes to specific sites is enhanced through bioconjugation.
• Recent strategies show promise for increased therapeutic efficacy.

Conclusions:

• Bioconjugation is a key strategy for advancing liposome drug delivery systems.
• These advancements are vital for liposomes in clinical trials.
• Future research will likely focus on novel bioconjugation methods for enhanced drug delivery.